The author of this article is Mr. Praveen Sikri, CEO of Ikris Pharma Network Supply of foolproof quality medicine for patient population and other end users must remain a non-negotiable priority for any drug regulatory authority. The responsibility becomes that much more exacting if the regulator happens to belong to and serve a country that […]
